DSM Pharmaceuticals, Inc. is a leading contract manufacturing and development company located in Greenville, North Carolina. With over 30 years of broad-based development and manufacturing experience, DSM Pharmaceuticals offers a level of performance unparalleled in the industry. By providing unmatched systems for quality, regulatory compliance, and project management, DSM Pharmaceuticals ensures a seamless transfer of operations through all phases of development and production.
DSM Pharmaceuticals, Inc. is dedicated to moving your products through most phases of development and production. Whether you need assistance with formulation and development, production scale-up, regulatory consultation, secondary manufacturing, or finial packaging, DSM Pharmaceuticals, Inc. is there for you every step of the way. Offering unmatched systems, unparalleled capacity, and unwavering commitment, at DSM Pharmaceuticals we're committed to partnerships, not just projects.
From its 600-acre site in Greenville, NC, DSM Pharmaceuticals, Inc. serves the pharmaceutical, biotech and veterinary markets worldwide. DSM Pharmaceuticals, Inc. has 100,000 gallons of primary reactor capacity, 120,000 square feet of development labs, 93,449 square feet of semi-solid capacity and 195,902 square feet of capacity for capsules and tablet production. It also has over 2,000 square feet of lyophilization capacity in 410,000 square feet of sterile products manufacturing capacity.
DSM Pharmaceuticals, Inc. R&D organization is comprised of five separate groups to support non-steriles and steriles development, clinical trial manufacture, packaging and labeling, analytical, regulatory affairs and project management.
DSM Pharmaceuticals, Inc. Oral and topical operations provides manufacturing, primary and secondary packaging of tablets, capsules, ointments, powders, creams, solutions, elixirs, suspensions and syrups.
DSM Pharmaceuticals, Inc. World-class steriles facility has continuous, recipe-driven, automated processing lines to wash, sterilize, fill, freeze-dry and cap at a rate of 300 to 400 units per minute.
Last Updated: 08-01-02